Literature DB >> 23420328

Clinical trial discussion, referral, and recruitment: physician, patient, and system factors.

Celia P Kaplan1, Anna Maria Nápoles, Daniel Dohan, E Shelley Hwang, Michelle Melisko, Dana Nickleach, Jessica Ann Quinn, Jennifer Haas.   

Abstract

PURPOSE: Patient participation in cancer clinical trials is imperative to the advancement of medical science. Physicians play an important role in recruitment by discussing clinical trials with their cancer patients. Patient-physician discussion is influenced by many factors relating to the physician, the patient, and the healthcare system.
METHODS: Physicians selected from the 2008-2009 American Medical Association Physician Masterfile who practiced in California, Florida, Illinois, or New York and specialized in medical oncology, surgery, or radiation oncology were surveyed about their attitudes and practices with respect to breast cancer clinical trials. Practice types were categorized according to the classifications provided by the American College of Surgeons, and clinical trial and practice addresses were geocoded.
RESULTS: Surveys were completed by 706 of 1,534 eligible physicians (46 %). Medical oncologists were more likely than surgical or radiation oncologists to discuss the possibility, benefits, and risks of clinical trial enrollment with their breast cancer patients. Physicians who spent the most time in patient care were least likely to discuss clinical trials with their patients. Distance from a physician's practice to the nearest clinical trial site was inversely associated with referral and recruitment. Perceived barriers to clinical trial participation were associated with greater referral activity suggesting that physicians who were more involved in trials were also more likely to understand barriers to participation.
CONCLUSIONS: Multilevel interventions may be successful at increasing participation of women in clinical trials.

Entities:  

Mesh:

Year:  2013        PMID: 23420328     DOI: 10.1007/s10552-013-0173-5

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  23 in total

Review 1.  Neurosurgical involvement in clinical trials for CNS tumors.

Authors:  Michael A Vogelbaum; Ian F Parney; J Bradley Elder; Daniel Cahill
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

2.  Attitudes of small animal practitioners toward participation in veterinary clinical trials.

Authors:  Margaret E Gruen; Emily H Griffith; Sarah M A Caney; Mark Rishniw; B Duncan X Lascelles
Journal:  J Am Vet Med Assoc       Date:  2017-01-01       Impact factor: 1.936

3.  The Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network: A New Model for Addressing Site-Level Factors Impacting Clinical Trial Enrollment.

Authors:  Michael Roth; Nupur Mittal; Aniket Saha; David R Freyer
Journal:  J Adolesc Young Adult Oncol       Date:  2020-02-20       Impact factor: 2.223

4.  Before Consent: Qualitative Analysis of Deliberations of Patients With Advanced Cancer About Early-Phase Clinical Trials.

Authors:  Sarah B Garrett; Thea M Matthews; Corey M Abramson; Christopher J Koenig; Fay J Hlubocky; Christopher K Daugherty; Pamela N Munster; Daniel Dohan
Journal:  JCO Oncol Pract       Date:  2019-10-11

5.  Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled Trials.

Authors:  Jennifer K Logan; Chad Tang; Zhongxing Liao; J Jack Lee; John V Heymach; Stephen G Swisher; James W Welsh; Jianjun Zhang; Steven H Lin; Daniel R Gomez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-11-27       Impact factor: 7.038

Review 6.  Adolescent and young adult patients with cancer: a milieu of unique features.

Authors:  Leonard Sender; Keri B Zabokrtsky
Journal:  Nat Rev Clin Oncol       Date:  2015-05-26       Impact factor: 66.675

7.  Willingness to participate in various nontherapeutic cancer research activities among urban and rural African American and Latinx healthy volunteers.

Authors:  Isabel C Scarinci; Barbara Hansen; B Lee Green; Stephen O Sodeke; Eboni G Price-Haywood; Young-Il Kim
Journal:  Cancer Causes Control       Date:  2022-04-11       Impact factor: 2.532

8.  Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers.

Authors:  S Manne; D Kashy; T Albrecht; Y-N Wong; A Lederman Flamm; A B Benson; S M Miller; Linda Fleisher; J Buzaglo; N Roach; M Katz; E Ross; M Collins; D Poole; S Raivitch; D M Miller; T G Kinzy; T Liu; N J Meropol
Journal:  Eur J Cancer Care (Engl)       Date:  2014-01-28       Impact factor: 2.520

9.  Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials.

Authors:  M J Overman; V Morris; B Kee; D Fogelman; L Xiao; C Eng; A Dasari; R Shroff; T Mazard; K Shaw; E Vilar; K Raghav; I Shureiqi; L Liang; G B Mills; R A Wolff; S Hamilton; F Meric-Bernstam; J Abbruzzese; J Morris; D Maru; S Kopetz
Journal:  Ann Oncol       Date:  2016-02-18       Impact factor: 32.976

Review 10.  Applying a Conceptual Framework to Maximize the Participation of Diverse Populations in Cancer Clinical Trials.

Authors:  A Napoles; E Cook; T Ginossar; K D Knight; M E Ford
Journal:  Adv Cancer Res       Date:  2016-10-05       Impact factor: 5.767

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.